Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$564M |
| 2 |
UnitedHealth
UNH
|
$439M |
| 3 |
Johnson & Johnson
JNJ
|
$353M |
| 4 |
Amazon
AMZN
|
$200M |
| 5 |
Microsoft
MSFT
|
$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$293M |
| 3 |
Kellanova
K
|
$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.95% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Pyxis Oncology
PYXS
$79.4M
| $35.8K | ﹤0.01% |
36,516
-74,535
| -67% | -$73K |
|
3277
Aprea Therapeutics
APRE
$9.12M
| $34K | ﹤0.01% |
16,655
-409
| -2% | -$834 |
|
|
TMQ
3278
Trilogy Metals
TMQ
$278M
| $33.6K | ﹤0.01% |
21,693
| – | – |
|
3279
Sonim Technologies
SONM
$10.4M
| $33.6K | ﹤0.01% |
15,706
-412
| -3% | -$882 |
|
|
AIFU
3280
AIFU Inc. Class A Ordinary Share
AIFU
$67.8M
| $33.5K | ﹤0.01% |
159,280
-296,846
| -65% | -$62.4K |
|
3281
Milestone Pharmaceuticals
MIST
$156M
| $31.7K | ﹤0.01% |
39,450
| – | – |
|
|
SBDS
3282
Solo Brands, Inc.
SBDS
$20.2M
| $31.3K | ﹤0.01% |
185,811
-224,968
| -55% | -$37.9K |
|
|
VXRT
3283
DELISTED
Vaxart
VXRT
| $30.7K | ﹤0.01% |
75,491
| – | – |
|
|
HOOK
3284
DELISTED
HOOKIPA Pharma
HOOK
| $30.7K | ﹤0.01% |
28,431
-20,204
| -42% | -$21.8K |
|
3285
Immunic
IMUX
$78.8M
| $30K | ﹤0.01% |
27,521
| – | – |
|
3286
Educational Development Corp
EDUC
$9.96M
| $29.3K | ﹤0.01% |
21,398
-1,355
| -6% | -$1.86K |
|
3287
Cambium Networks
CMBM
$19.2M
| $28.7K | ﹤0.01% |
40,695
-13,472
| -25% | -$9.5K |
|
3288
Battalion Oil
BATL
$19.3M
| $28.3K | ﹤0.01% |
21,769
-1,791
| -8% | -$2.33K |
|
|
LGO
3289
Largo
LGO
$94.9M
| $27.2K | ﹤0.01% |
16,872
| – | – |
|
3290
Arts-Way Manufacturing Co
ARTW
$16.1M
| $26.7K | ﹤0.01% |
16,797
| – | – |
|
3291
Energy Vault
NRGV
$340M
| $26.7K | ﹤0.01% |
38,334
+4,697
| +14% | +$3.27K |
|
3292
PharmaCyte Biotech
PMCB
$6.39M
| $25.4K | ﹤0.01% |
20,299
-6,542
| -24% | -$8.18K |
|
3293
Beam Global
BEEM
$49.2M
| $25.2K | ﹤0.01% |
12,376
| – | – |
|
3294
Carver Bancorp
CARV
$11.8M
| $24.5K | ﹤0.01% |
17,408
| – | – |
|
3295
Sidus Space
SIDU
$30.8M
| $24.5K | ﹤0.01% |
+16,579
| New | +$24.5K |
|
3296
Babcock & Wilcox
BW
$245M
| $23.4K | ﹤0.01% |
34,739
| – | – |
|
|
FLNT
3297
Fluent
FLNT
$53.1M
| $23.1K | ﹤0.01% |
+10,581
| New | +$23.1K |
|
3298
PDS Biotechnology
PDSB
$58.3M
| $21.9K | ﹤0.01% |
18,382
-8
| -0% | -$10 |
|
3299
Great Elm Group
GEG
$75M
| $21.6K | ﹤0.01% |
11,419
| – | – |
|
|
IGMS
3300
DELISTED
IGM Biosciences
IGMS
| $21.2K | ﹤0.01% |
18,376
-228
| -1% | -$262 |
|